Literature DB >> 16179814

Psychopathologic correlates of suicidal ideation in major depressive outpatients: is it all due to unrecognized (bipolar) depressive mixed states?

Hagop S Akiskal1, Franco Benazzi.   

Abstract

BACKGROUND: Recent transatlantic concern about suicidality in patients receiving antidepressants prompted us to examine the psychopathologic correlates of suicidal ideation occurring in clinically depressed patients.
METHODS: The study sample, which consisted of 644 consecutive major depressive outpatients, of which 58.0% had bipolar II disorder (BP-II), was systematically interviewed with the SCID, in order to delineate the diagnostic and psychopathologic correlates of suicidal ideation.
RESULTS: Such ideation, which was present in 49.5% [and favoring BP-II vs. major depressive disorder (MDD)] at an odds ratio (OR) of 1.3 (95% confidence interval = 0.98-1.8), was clinically significantly associated with depressive mixed state (racing/crowded thoughts and psychomotor agitation/activation during index depression), mood lability, decreased self-esteem, anorexia, as well as melancholic and psychotic features. Multiple logistic regression of suicidal ideation versus depressive symptoms and intradepressive excitatory symptoms revealed that decreased self-esteem (OR = 3.3), racing/crowded thoughts (OR = 1.5), and psychomotor agitation/activation (OR = 1.4) were independent and clinically significant correlates of suicidal ideation, irrespective of depression severity. DISCUSSION: From a psychopathologic standpoint, suicidality might be conferred by a combination of both the excited (mixed) depressive and agitated (melancholic) clusters. Trait mood lability appears to favor the genesis of these affective clusters. Within the framework of Kraepelinian psychiatry, both clusters represent depressive mixed states. Given that such states are more prevalent in BP-II, our data provide a possible explanation for the greater suicidality in BP-II patients reported in the literature. In light of the higher odds of suicidal ideation in BP-II versus MDD patients, we hypothesize that the higher prevalence of mental and psychomotor activation in BP-II might be one factor among others that favors the greater likelihood of the transition from suicidal ideation to suicidal action in BP-II. Our analyses delineate a mixed depressive substrate at risk for suicidality. To what extent, if any, antidepressant monotherapy might contribute to the genesis of such states and/or suicidality cannot be answered with the methodology of the present study.

Entities:  

Mesh:

Year:  2005        PMID: 16179814     DOI: 10.1159/000088445

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  16 in total

1.  Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes.

Authors:  Lewis L Judd; Pamela J Schettler; Hagop Akiskal; William Coryell; Jan Fawcett; Jess G Fiedorowicz; David A Solomon; Martin B Keller
Journal:  J Affect Disord       Date:  2012-02-06       Impact factor: 4.839

Review 2.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

3.  Differentiating bipolar disorder from unipolar depression in youth: A systematic literature review of neuroimaging research studies.

Authors:  Caroline Kelberman; Joseph Biederman; Allison Green; Vincenza Spera; Marco Maiello; Mai Uchida
Journal:  Psychiatry Res Neuroimaging       Date:  2020-10-05       Impact factor: 2.376

4.  The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine Care.

Authors:  Angela M Bengtson; Brian W Pence; Katie R Mollan; Jessie K Edwards; Richard D Moore; Conall OʼCleirigh; Ellen F Eaton; Joseph J Eron; Mari M Kitahata; William C Mathews; Heidi Crane; Michael J Mugavero
Journal:  J Acquir Immune Defic Syndr       Date:  2017-12-01       Impact factor: 3.731

5.  Objectively Assessed Sleep Variability as an Acute Warning Sign of Suicidal Ideation in a Longitudinal Evaluation of Young Adults at High Suicide Risk.

Authors:  Rebecca A Bernert; Melanie A Hom; Naomi G Iwata; Thomas E Joiner
Journal:  J Clin Psychiatry       Date:  2017-06       Impact factor: 4.384

6.  Duration of untreated illness and suicide in bipolar disorder: a naturalistic study.

Authors:  A Carlo Altamura; Bernardo Dell'Osso; Heather A Berlin; Massimiliano Buoli; Roberta Bassetti; Emanuela Mundo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11-13       Impact factor: 5.270

Review 7.  Suicidal behaviour in mood disorders--who, when, and why?

Authors:  Erkki Isometsä
Journal:  Can J Psychiatry       Date:  2014-03       Impact factor: 4.356

8.  Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015.

Authors:  Angela M Bengtson; Brian W Pence; Ellen F Eaton; Jessie K Edwards; Joseph J Eron; William C Mathews; Katie Mollan; Richard D Moore; Connall O'Cleirigh; Elvin Geng; Michael J Mugavero
Journal:  Antivir Ther       Date:  2018

9.  Antidepressant-resistant depression and antidepressant-associated suicidal behaviour: the role of underlying bipolarity.

Authors:  Zoltan Rihmer; Xenia Gonda
Journal:  Depress Res Treat       Date:  2011-04-03

10.  Suicidality and suicide attempt in a young female on long-term sertraline treatment.

Authors:  Ranjita Santra; Patralekha Ray Chaudhuri; Dibyendu Dhali; Shirsendu Mondal
Journal:  Indian J Psychol Med       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.